×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [27]
吉林大学白求恩第一... [25]
复旦大学上海医学院 [12]
昆明医科大学 [11]
湖南大学 [8]
上海药物研究所 [7]
更多...
内容类型
期刊论文 [98]
会议论文 [19]
发表日期
2022 [2]
2021 [2]
2020 [3]
2019 [17]
2018 [22]
2017 [16]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共117条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study
期刊论文
CANCER MEDICINE, 2022
作者:
Yu, Xiaoqing
;
Si, Jinfei
;
Wei, Jingwen
;
Wang, Yanling
;
Sun, Yan
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2022/12/23
EGFR-TKIs
non-small cell lung cancer (NSCLC)
real-world study
survival outcome
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
Jin, Ying
;
Lin, Chen
;
Shi, Xun
;
He, Qiong
;
Yan, Junrong
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/23
Clinical and molecular features
Efficacy and outcome
EGFR T790M mutation
Non-small-cell lung cancer
Osimertinib
Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)
期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2021
作者:
Si, Jinfei
;
Gu, Xiaodong
;
Wang, Wenxian
;
Ying, Shenpeng
;
Song, Zhengbo
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2022/02/14
Epidermal growth factor receptor (EGFR)
uncommon mutation
compound mutation
double uncommon mutation
lung adenocarcinoma (lung AC)
Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study
期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 11
作者:
Song, Zhengbo
;
Lv, Dongqing
;
Chen, Shiqing
;
Huang, Jianhui
;
Wang, Liping
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2021/06/21
non-small cell lung cancer (NSCLC)
HER2
afatinib
efficacy
resistance
Simultaneous determination of sutetinib and its active metabolite sutetinibN-oxide in human plasma by liquid chromatography-tandem mass spectrometry: Evaluation of plasma stability
期刊论文
BIOMEDICAL CHROMATOGRAPHY, 2020, 页码: 9
作者:
Qiu, Yanan
;
Tang, Chongzhuang
;
Li, Ranran
;
Cao, Sumin
;
Zhang, Yuqiang
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2020/12/24
LC-MS
MS
N-oxide
stability
sutetinib
EGFR exon 20 insertion mutations in non-small cell lung cancer
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:
Wang, Fenfang
;
Li, Chenghui
;
Wu, Qihuan
;
Lu, Hongyang
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2020/11/26
EGFR exon 20 insertion mutations
non-small cell lung cancer (NSCLC)
EGFR-TKIs
structural features
clinical features
treatment
prognosis
Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC
期刊论文
JOURNAL OF CANCER, 2020, 卷号: 11, 期号: 1, 页码: 241-250
作者:
Zhang, Yan
;
Yang, Xinying
;
Liu, Hongchun
;
Cai, Minghui
;
Yang Shentu
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/07/01
EGFR-TKIs
NSCLC
lymphangiogenesis
JAK/STAT3
LYVE-1
Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib A case report
期刊论文
MEDICINE, 2019, 卷号: 98, 期号: 1
作者:
Cai, Yangyang
;
Wang, Xu
;
Guo, Ye
;
Sun, Chao
;
Xu, Yinghui
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/12/05
afatinib
EGFR exon 20-ins mutation
EGFR-TKI
lung cancer
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China
期刊论文
LUNG CANCER, 2019, 卷号: 127
作者:
Gu, Xiaohua
;
Zhang, Qiang
;
Chu, Yun-Bo
;
Zhao, Yi-Yang
;
Zhang, Yan-Jun
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/12/05
Afatinib
EGFR mutation
Cost-effectiveness
Non-small cell lung cancer
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China
期刊论文
Lung Cancer, 2019, 卷号: Vol.127, 页码: 84-89
作者:
Xiaohua Gu
;
Qiang Zhang
;
Yun-Bo Chu
;
Yi-Yang Zhao
;
Yan-Jun Zhang
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/13
Afatinib
EGFR
mutation
Cost-effectiveness
Non-small
cell
lung
cancer
©版权所有 ©2017 CSpace - Powered by
CSpace